Our analysis highlight that both Bcl‐xL mRNA and protein levels are up‐regulated in total leucocyte and in erythroblasts of PV and PMF and in hematopoietic progenitors of patients from all MPN subgroups compared to healthy donors, confirming and implementing published data.18, 19. The gene discussed is BCL2L1; the disease is myeloproliferative disorder.